The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

novaremed.com

Founded Year

2018

Stage

Line of Credit | Alive

Total Raised

$65.83M

Last Raised

$50M | 1 yr ago

About Novaremed

Novaremed is a clinical-stage Swiss biopharmaceutical company developing an orally active, small molecule (NRD.E1) to treat Diabetic Neuropathic Pain.

Novaremed Headquarter Location

Teichgaesslein 9

Basel, 4058,

Switzerland

+41 61 317 93 26

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Novaremed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novaremed is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Diabetes

1,750 items

Novaremed Patents

Novaremed has filed 5 patents.

The 3 most popular patent topics include:

  • Amines
  • Benzamides
  • Enantiopure drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/30/2014

7/5/2016

Stereochemistry, Amines, Benzamides, Piperidines, Enantiopure drugs

Grant

Application Date

5/30/2014

Grant Date

7/5/2016

Title

Related Topics

Stereochemistry, Amines, Benzamides, Piperidines, Enantiopure drugs

Status

Grant

Latest Novaremed News

Novaremed’s lead molecule enters Phase2b trials

Dec 29, 2021

The National Institutes of Health (NIH) will sponsor and conduct a clinical Phase 2b study with Novaremed’s lead non-opioid development compound NRD.E1 in the treatment of painful diabetic peripheral neuropathy (PDPN). The trial builds on Phase 2a proof-of-concept study in PDPN, which showed a clinically relevant reduction in patient-reported pain and good tolerability of NRD.E1.

Novaremed Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Novaremed Rank

  • When was Novaremed founded?

    Novaremed was founded in 2018.

  • Where is Novaremed's headquarters?

    Novaremed's headquarters is located at Teichgaesslein 9, Basel.

  • What is Novaremed's latest funding round?

    Novaremed's latest funding round is Line of Credit.

  • How much did Novaremed raise?

    Novaremed raised a total of $65.83M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.